| Literature DB >> 30472699 |
Melek Erdem1, Özlem Tüfekçi1, Şebnem Yılmaz1, İnci Alacacıoğlu2, Hale Ören3.
Abstract
Dyskeratosis congenita (DC) is a rare inherited syndrome characterized by classical mucocutaneous features and the presence of other clinical features including bone marrow failure, pulmonary fibrosis, liver cirrhosis, and a predisposition to cancer. The symptoms develop at various ages and may manifest over time. Gene mutations associated with DC, such as DC1, TERC, TERT, TINF2, NHP2, NOP10, ACD, CTC1, NAF1, PARN, POT1, RTEL1, STN1, and WRAP53, have been identified in about 70% of patients. Since the number of patients with DC is small and the effect of genetic pathogenic variant may affect the phenotype, we wanted to present the clinical features and course of illness in a patient with NHP2 gene mutation (compound heterozygote for the NHP2 mutations c.376G>A/c.460T>A; amino acid substitutions: p.Val126Met and p.X154Arg) that occurred as a compound heterozygous state.Entities:
Keywords: Bone marrow failure; Dyskeratosis congenita; NHP2 mutation
Mesh:
Substances:
Year: 2018 PMID: 30472699 DOI: 10.1159/000494421
Source DB: PubMed Journal: Acta Haematol ISSN: 0001-5792 Impact factor: 2.195